Lanstead Capital

Lanstead Partners Ltd. is an investment firm in Australia focused on providing new equity capital to publicly listed companies. Founded 2008 in Sydney, New South Wales, Australia by Gregory L. Kofford and Mark W. Holden, this government office invests in post-IPO rounds, Its portfolio companies include ImmuPharma and Synchronica. As of February 2020, Lanstead Capital has made four investments. Their most recent investment was on February 10, 2016, when ImmuPharma raised £8.3M. Lanstead Capital has had two exits, the most notable of which include ImmuPharma and Synchronica. The firm typically invests between $3 million and $30 million.